TABLE 2.
Age-specific prevalence rates of MuV antibodies in the healthy control group
Age group (yr) | No. of individuals | Vaccination status | % Positive for MuV IgG | Avg MuV IgG TV |
---|---|---|---|---|
0-4 | 13 | Vaccinated | 92.3 | 1.9 |
5-9 | 19 | Vaccinated | 68.4 | 1.4 |
10-15 | 16 | Vaccinated | 43.8 | 1.0 |
>15 | 3 | Nonvaccinated | 100.0 | 2.7 |